605,648-share sale and 10b5-1 plan trades at Alignment Healthcare (ALHC)
Rhea-AI Filing Summary
Alignment Healthcare, Inc. reported proposed and recent sales of its common stock by a trust and an individual in a Form 144 disclosure. The filing lists multiple 10b5-1 plan sales including 180,000 shares on
Positive
- None.
Negative
- None.
Insights
Form 144 lists multiple planned and completed sales under a 10b5-1 plan and an individual sale.
The filing shows recurring 10b5-1 plan sales by JEK Trust — three entries of 180,000 shares each on
Cash‑flow treatment and buyer identities are not stated in the excerpt; timing and pattern suggest systematic plan activity. Subsequent filings or broker statements would show net proceeds and any remaining plan limits.
Transactions are reported under Rule 144 and reference a 10b5-1 sales plan and RSU vesting.
The disclosure cites an RSU vesting event of 124,172 shares on
Relevant qualifiers (plan name, trust document date) are included verbatim. Any regulatory compliance implications depend on trade execution details and are not specified in the provided excerpt.
FAQ
What sales does Alignment Healthcare (ALHC) disclose in this Form 144?
Who executed the sales reported in the Form 144 for ALHC?
Do the filings show whether the sales were under a 10b5-1 plan?
Were any shares acquired by vesting noted in the Form 144?
Does the Form 144 state how much cash was received from the sales?